Highlights Precipio, Inc.

Equities

PRPO

US74019L6020

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-17 pm EDT			5-day change	1st Jan Change
6.29 ^USD	+1.29%		+4.23%	-3.23%

Apr. 19	Precipio, Inc. announced that it expects to receive $0.5 million in funding	CI
Apr. 01	Transcript : Precipio, Inc. - Special Call

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Precipio, Inc. and Cardinal Health Sign Distribution Agreement for Its HemeScreen®? Portfolio of Molecular Assays for Cancer	Feb. 06	CI
Precipio Signs Distribution Deal in Japan, Gets First Order; Shares Rise	Jan. 17	MT
Precipio, Inc. Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan	Jan. 17	CI
Precipio, Inc. Announces Board Changes	Jan. 02	CI
Precipio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Reverse Split: 1 of 20	23-09-21	FA
Precipio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
End in sight for U.S. insider trading case over healthcare leaks	23-08-01	RE
Precipio's Omnia?? Methodology Enables Diagnosis of MDS with Peripheral Blood Instead of Bone Marrow Biopsy	23-06-14	CI
Precipio, Inc. Enters into Collaboration with Prestigious New York-Based Institution to Develop Revolutionary Brain Tumor Panel Using Hemescreen Technology	23-06-13	CI
Precipio, Inc.'s Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology	23-05-22	CI
Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Precipio Signs Another HemeScreen™? Customer	23-05-04	CI
Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Precipio Sees Q1 Revenue Nearly Trebling After Signing Deal for HemeScreen Technology With New Customer; Shares Jump	23-01-11	MT
Precipio Signs Another Major HemeScreen Customer	23-01-11	CI
Insider trading convictions over healthcare leaks are voided by U.S. appeals court	22-12-27	RE
Precipio, Inc. Signs Additional Major HemeScreen Customer	22-12-06	CI
Precipio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Precipio, Inc.

Equities

PRPO

US74019L6020

Highlights

Filters